First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer
(2017)
Autori:
Dieci, Maria Vittoria; Guarneri, Valentina; Giarratano, Tommaso; Mion, Marta; Tortora, Giampaolo; De Rossi, Costanza; Gori, Stefania; Oliani, Cristina; Merlini, Laura; Pasini, Felice; Bonciarelli, Giorgio; Griguolo, Gaia; Orvieto, Enrico; Michieletto, Silvia; Saibene, Tania; Del Bianco, Paola; De Salvo, Gian Luca; Conte, Pierfranco
Titolo:
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer
Anno:
2017
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
A Stampa
Referee:
Sì
Nome rivista:
THE ONCOLOGIST
ISSN Rivista:
1083-7159
Intervallo pagine:
N/D-N/D
Parole chiave:
Adjuvant chemotherapy; Early breast cancer; Estrogen receptor positive; Recurrence score; Treatment change
Breve descrizione dei contenuti:
The Breast DX Italy prospective study evaluated the impact of the 21-gene recurrence score (RS) result on adjuvant treatment decisions for patients with early breast cancer.
Id prodotto:
101429
Handle IRIS:
11562/975333
ultima modifica:
14 novembre 2022
Citazione bibliografica:
Dieci, Maria Vittoria; Guarneri, Valentina; Giarratano, Tommaso; Mion, Marta; Tortora, Giampaolo; De Rossi, Costanza; Gori, Stefania; Oliani, Cristina; Merlini, Laura; Pasini, Felice; Bonciarelli, Giorgio; Griguolo, Gaia; Orvieto, Enrico; Michieletto, Silvia; Saibene, Tania; Del Bianco, Paola; De Salvo, Gian Luca; Conte, Pierfranco,
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer«THE ONCOLOGIST»
, 2017
, pp. N/D-N/D